Triki Hinda, Barbouche Mohamed Ridha, Bahri Olfa, Bejaoui Mohamed, Dellagi Koussay
Laboratory of Clinical Virology, WHO Regional Reference Laboratory on Poliomyelitis, Tunis, Tunisia.
J Clin Microbiol. 2003 Mar;41(3):1203-11. doi: 10.1128/JCM.41.3.1203-1211.2003.
The global polio eradication program recommends the use of massive vaccination campaigns with live vaccine through National Immunization Days (NIDs) to displace the wild virus from the community. Immunodeficient patients may be indirectly infected and become chronic excretors and potential reservoirs of polioviruses, a concern for the posteradication era. This prospective study aimed to assess the risk of community-acquired infection of immunodeficient patients following NIDs, the dynamics of viral excretion and the genetic variation of excreted viruses. Sixteen children with various primary immunodeficiencies, who did not receive the vaccine during the campaign, were investigated. Stool samples were collected weekly, shortly after the NIDs, during at least 3 months, and were processed for viral isolation. Isolates were characterized by three intratypic differentiation methods and partial sequencing of the VP1/2A region. Polioviruses were detected in 4 out of 16 patients (serotype 1 in 3 patients and serotype 3 in 1 patient). Sequencing revealed more than 99% homology with homotypic Sabin strains, suggesting recent infection. Duration of viral excretion ranged from 1 to 7 weeks. Nine out of eleven isolates from the three poliovirus serotype 1-infected patients disclosed a non-Sabin-like phenotype by enzyme-linked immunosorbent assay and had recurrent mutations within or close to the neutralizing antigenic sites. In summary, the risk of secondary infection in immunodeficient patients is within the range previously reported for the general population. Although none of the four infected patients developed prolonged viral excretion, particular viral variants were selected and may be of epidemiological significance.
全球根除脊髓灰质炎计划建议通过国家免疫日(NIDs)开展大规模的活疫苗接种运动,以将野生病毒从社区中清除。免疫功能低下的患者可能会被间接感染,并成为脊髓灰质炎病毒的慢性排泄者和潜在储存宿主,这是根除后时代的一个问题。这项前瞻性研究旨在评估国家免疫日后免疫功能低下患者社区获得性感染的风险、病毒排泄动态以及排泄病毒的基因变异情况。对16名患有各种原发性免疫缺陷且在运动期间未接种疫苗的儿童进行了调查。在国家免疫日后至少3个月内,每周采集一次粪便样本,用于病毒分离。通过三种型内鉴别方法和VP1/2A区域部分测序对分离株进行鉴定。16名患者中有4名检测到脊髓灰质炎病毒(3名患者为1型,1名患者为3型)。测序显示与同型萨宾株的同源性超过99%,表明为近期感染。病毒排泄持续时间为1至7周。来自三名感染1型脊髓灰质炎病毒患者的11株分离株中,有9株通过酶联免疫吸附试验显示出非萨宾样表型,并且在中和抗原位点内或附近有反复突变。总之,免疫功能低下患者继发感染的风险在先前报道的普通人群范围内。虽然四名感染患者中没有一人出现病毒长期排泄,但特定的病毒变异体被筛选出来,可能具有流行病学意义。